ANGEL PLACIDO
LLANEZA COTO
Catedrático de Universidad
María Jesús
Cancelo Hidalgo
María Jesús Cancelo Hidalgo-rekin lankidetzan egindako argitalpenak (11)
2022
2020
-
Managing thromboembolic risk with menopausal hormone therapy and hormonal contraception in the COVID-19 pandemic: Recommendations from the Spanish Menopause Society, Sociedad Española de Ginecología y Obstetricia and Sociedad Española de Trombosis y Hemostasia
Maturitas, Vol. 137, pp. 57-62
-
Response to “Should estrogen be used in the co-treatment of COVID-19 patients?”
Maturitas
-
The thromboembolic risk in covid-19 women under hormonal treatment group
Maturitas
2019
-
Impact Of Vulvovaginal Atrophy Of Menopause In Spanish Women: Prevalence And Symptoms According To The EVES Study
Sexual Medicine, Vol. 7, Núm. 2, pp. 207-216
2018
-
Aeem-sego position statement on menopausal hormone therapy
Progresos de Obstetricia y Ginecologia, Vol. 61, Núm. 3, pp. 230-234
2017
-
Vulvar and vaginal atrophy as viewed by the Spanish REVIVE participants: symptoms, management and treatment perceptions
Climacteric, Vol. 20, Núm. 1, pp. 55-61
2013
-
2013 Up-date of the consensus statement of the Spanish Menopause Society on postmenopausal osteoporosis
Maturitas, Vol. 76, Núm. 1, pp. 99-107
-
Spanish Menopause Society position statement: Use of tibolone in postmenopausal women
Menopause, Vol. 20, Núm. 7, pp. 754-760
2002
2001
-
Valoración de la eficacia y seguridad de una preparación de fitoestrógenos extraídos de la soja (Glycine max L.) en el tratamiento de la sintomatología climatérica. Resultados de un ensayo piloto multicéntrico, abierto y prospectivo
Toko-Ginecologia Practica, Vol. 60, Núm. 654, pp. 257-264